Visby Medical
Our mission is to provide fast and accurate PCR results right at the point of care.
Our mission is to provide fast and accurate PCR results right at the point of care.
Visby Medical, founded in 2012 , is a Health Care startup with a mission to provide fast and accurate PCR results right at the point of care. The company has developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections. This innovation is reshaping the order of diagnosis and treatment for infectious diseases, enabling clinicians to test, talk with, and treat the patient in a single visit. Based in the United States , the company received a $1.80M grant investment from CARB-X on 08 February 2024. Visby Medical's groundbreaking approach to point-of-care testing presents a significant opportunity in the healthcare industry, with the potential to revolutionize patient care and disease management.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $3.90M | 1 |
|
15 Jan 2025 |
| Grant | $1.80M | 1 |
|
08 Feb 2024 |
| Series E | $35.00M | 5 |
|
29 Jun 2022 |
| Grant | $25.50M | 1 | Biomedical Advanced Research and Development Authority (BARDA) | 22 Mar 2022 |
| Series E | $100.00M | 9 |
|
01 Mar 2022 |
No recent news or press coverage available for Visby Medical.
We care about your data, and we'd love to use cookies make your experience better.
